Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Recommendations for diagnosis and management of multiple sclerosis.
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Role of statins in the treatment of multiple sclerosis.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
PLEGRIDY™ (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients
Pain Research Forum: application of scientific social media frameworks in neuroscience.
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Patient perceptions of multiple sclerosis and its treatment.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
The microglial sensome revealed by direct RNA sequencing.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »